주식/증권
📈 긍정적
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
요약
Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 9.3% gain during that period.